| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/25/2005 | US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases |
| 08/25/2005 | US20050187284 Integrin receptor inhibitors |
| 08/25/2005 | US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 08/25/2005 | US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints |
| 08/25/2005 | US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5) |
| 08/25/2005 | US20050187226 A1 adenosine receptor antagonists |
| 08/25/2005 | US20050187185 for tautening skin, in particular for reducing the size of wrinkles in the facial region in a long-lasting manner; comprising crosslinked or uncrosslinked hyaluronic acid associated with heparin |
| 08/25/2005 | US20050187164 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof |
| 08/25/2005 | US20050187152 Prevention and treatment of hypergastrinemia |
| 08/25/2005 | US20050186663 Cystine-knot fold protein |
| 08/25/2005 | US20050186620 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/25/2005 | US20050186220 derived from canine distemper virus; vaccines for inducing immune response |
| 08/25/2005 | US20050186186 Tumor cell having DcR3/TR6, a new member of the TNFR family, anchored at its surface |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit |
| 08/25/2005 | CA2558879A1 Regulatory cell controlling immunological activity of t cell |
| 08/25/2005 | CA2556086A1 Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors |
| 08/25/2005 | CA2555503A1 Humanized anti-cd3 bispecific binding molecules having reduced immunogenicity, uses and compositions relating thereto |
| 08/25/2005 | CA2555319A1 Inhibiting cav3 isoforms and the .delta.25b splice variants for the diagnosis and treatment of cancer |
| 08/25/2005 | CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins |
| 08/25/2005 | CA2554378A1 Bicycloamide derivative |
| 08/24/2005 | EP1566379A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 08/24/2005 | EP1565432A1 Histone deacetylase inhibitors |
| 08/24/2005 | EP1565431A1 Cannabinoid receptor ligands |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565210A2 Treatment of mammalian reaction to ige interactions |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565197A1 Papaya puree and the use of the same |
| 08/24/2005 | EP1565183A1 Rapamycin and il-10 for the treatment of immune diseases |
| 08/24/2005 | EP1565179A1 Composition comprising a carbamic acid derivative, its use as cosmetic and medicine |
| 08/24/2005 | EP1565158A1 Oxazolidinones for cosmetic and pharmaceutical use in skin pathologies |
| 08/24/2005 | EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 08/24/2005 | EP1360185B1 Carboline derivatives |
| 08/24/2005 | EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 08/24/2005 | EP1335917B1 Condensed pyridoindole derivatives |
| 08/24/2005 | EP1284722B1 Compositions containing a benzamide disulfide derivative for treating allergic diseases |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | EP0996438B1 Use of cis-6-hexadecenoic acid esters for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens |
| 08/24/2005 | CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 08/24/2005 | CN1659161A Piperidine derivatives having CCR3 antagonism |
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659146A Process for the manufacture of quinoline derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/24/2005 | CN1658924A Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 08/24/2005 | CN1658906A Mycoplasma polypeptides |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 08/24/2005 | CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/24/2005 | CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 08/24/2005 | CN1658872A Antiallergic |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658857A NF-kB activation inhibitors |
| 08/24/2005 | CN1658855A O-substituted hydroxyaryl derivatives |
| 08/24/2005 | CN1658854A Immunity-related protein kinase inhibitors |
| 08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/24/2005 | CN1658767A Composition for modulating a physiological reaction or inducing an immune response |
| 08/24/2005 | CN1657617A Clone, expression and anti-tick immanoprotection action of falcate rhipicephalus RhcA and RhcB genes |
| 08/24/2005 | CN1657077A Medicinal diet milk tablet capable of strengthoning immune function and its manufacturing method |
| 08/24/2005 | CN1657044A Chlorretadin oral disintegrating tablet and its preparation method |
| 08/24/2005 | CN1215877C Recombined human interleukin-2 injection and preparing method thereof |
| 08/24/2005 | CN1215851C Buccal tablet of Qingqian willow leaf |
| 08/24/2005 | CN1215849C Method for preparing baicalin liquid |
| 08/24/2005 | CN1215801C Disease-proof health-care beverage and its producing process |
| 08/23/2005 | US6933386 Process for preparing certain pyrrolotriazine compounds |
| 08/23/2005 | US6933314 Integrin receptor inhibitors |
| 08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 08/23/2005 | US6933305 Amide compounds and use thereof |
| 08/23/2005 | US6933303 Antidiabetic agents |
| 08/23/2005 | US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy |
| 08/23/2005 | US6933129 Method for culturing and assaying cells |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932973 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration |
| 08/23/2005 | US6932972 Combined vaccine compositions |
| 08/23/2005 | US6932969 Ig fractions having immunomodulatory activity |
| 08/23/2005 | CA2266884C Inhibition of 26s and 20s proteasome by indanones |
| 08/23/2005 | CA2119006C Composition and method of treating hepatitis c |
| 08/23/2005 | CA2070281C Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
| 08/18/2005 | WO2005075628A1 Deactivated b1b cell |